Corrigendum to “Immunotherapeutic advances in pediatric neuroblastoma: Overcoming resistance through biomarker-guided combinations”, [Biomed. Pharmacother. 196 (2026) 119020] - 24/09/26

Mahla Shokouhfar ^a, 1

  Co-first authors

, Ali Darzi ^a, 1

  Co-first authors

, Fatemeh Ameli ^b, 2

  Contributed equally

, Mohammad Taha Nami ^c, 2

  Contributed equally

, Saeed Khavari Khorasani ^d, Pooya Eini ^e, Ahmad Ghorbani Vanan ^{f, ⁎} , Nastaran Bahrami ^{g, h, ⁎}

^a School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran 

^b School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran 

^c Faculty of Life Science and Biotechnology, Shahid Beheshti University, Tehran, Iran 

^d School of Medicine, Islamic Azad University, Bojnourd Branch, North Khorasan, Iran 

^e Cardiovascular Research Center, Rajaie Cardiovascular Institute, Tehran, Iran 

^f Student Research Committee, Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran 

^g Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran 

^h Department of Biology, Islamic Azad University, Science and Research Branch, Tehran, Iran 

^⁎ Corresponding author. ^⁎⁎ Corresponding author at: Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences Tehran Iran

Le texte complet de cet article est disponible en PDF.